We rescue neurons
to treat brain
diseases
Ceres Brain Therapeutics, established in 2019, is the brainchild of esteemed researchers and engineers from the prestigious French Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA). This venture is a fusion of innovative French R&D approaches and extensive expertise in healthcare and drug development. The founders, a team of highly skilled professionals, bring a rich blend of experience and insights, aiming to set new benchmarks in the healthcare sector. Their combined knowledge and foresight have positioned Ceres Brain Therapeutics as a leader in the field, dedicated to addressing complex medical challenges.
Who we are?
Our mission is to transform the way neurological diseases, particularly those stemming from bioenergetic deficiencies, are treated. We recognize the gaps in current treatment methodologies where effective compounds, like creatine—a small amino acid produced by the body and found in various foods—fail to reach the neurons, the brain's primary energy consumers. Our innovative strategies and pioneering research focus on neuron rescue, offering a beacon of hope for patients. This groundbreaking work is about reshaping the future of neurological healthcare and significantly improving patient outcomes.
What do we do?
CERES BRAIN Therapeutics aspires to revolutionize the treatment paradigm for neurological diseases characterized by bioenergetic deficiencies.
Our headquarters at Ceres Brain Therapeutics is strategically located in the Paris Brain Institute (ICM) within the Pitié-Salpêtriere University Hospital, a nexus of neuroscientific research in Paris. In addition, our laboratories operate under a collaborative agreement within the Paris-Saclay center of the CEA, situated about 30 km south of Paris. This unique placement facilitates a symbiotic relationship with both the Paris Brain Institute and the CEA, creating a fertile ground for innovative research and development. It is more than a location; it’s a hub of scientific synergy, playing an integral role in enriching and validating our clinical applications.